Works matching AU Menke-van der Houven van Oordt, Willemien C.


Results: 46
    1
    2
    3
    4
    5

    RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer.

    Published in:
    Molecular Oncology, 2019, v. 13, n. 11, p. 2361, doi. 10.1002/1878-0261.12550
    By:
    • Helden, Erik J.;
    • Angus, Lindsay;
    • Menke‐van der Houven van Oordt, C. Willemien;
    • Heideman, Daniëlle A. M.;
    • Boon, Eline;
    • Es, Suzanne C.;
    • Radema, Sandra A.;
    • Herpen, Carla M. L.;
    • Groot, Derk Jan A.;
    • Vries, Elisabeth G. E.;
    • Jansen, Maurice P. H. M.;
    • Sleijfer, Stefan;
    • Verheul, Henk M. W.
    Publication type:
    Article
    6

    <sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1944, doi. 10.2967/jnumed.121.263470
    By:
    • Verhoeff, Sarah R.;
    • van de Donk, Pim P.;
    • Aarntzen, Erik H. J. G.;
    • Oosting, Sjoukje F.;
    • Brouwers, Adrienne H.;
    • Miedema, Iris H. C.;
    • Voortman, Jens;
    • Menke-van der Houven van Oordt, Willemien C.;
    • Boellaard, Ronald;
    • Vriens, Dennis;
    • Slingerland, Marije;
    • Hermsen, Rick;
    • van Engen-van Grunsven, Ilse;
    • Heskamp, Sandra;
    • van Herpen, Carla M. L.
    Publication type:
    Article
    7

    <sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
    By:
    • Verhoeff, Sarah R.;
    • van de Donk, Pim P.;
    • Aarntzen, Erik H. J. G.;
    • Oosting, Sjoukje F.;
    • Brouwers, Adrienne H.;
    • Miedema, Iris H. C.;
    • Voortman, Jens;
    • Menke-van der Houven van Oordt, Willemien C.;
    • Boellaard, Ronald;
    • Vriens, Dennis;
    • Slingerland, Marije;
    • Hermsen, Rick;
    • Engen-van Grunsven, Ilse van;
    • Heskamp, Sandra;
    • van Herpen, Carla M. L.
    Publication type:
    Article
    8

    <sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263470
    By:
    • Verhoeff, Sarah R.;
    • van de Donk, Pim P.;
    • Aarntzen, Erik H. J. G.;
    • Oosting, Sjoukje F.;
    • Brouwers, Adrienne H.;
    • Miedema, Iris H. C.;
    • Voortman, Jens;
    • Menke-van der Houven van Oordt, Willemien C.;
    • Boellaard, Ronald;
    • Vriens, Dennis;
    • Slingerland, Marije;
    • Hermsen, Rick;
    • van Engen-van Grunsven, Ilse;
    • Heskamp, Sandra;
    • van Herpen, Carla M. L.
    Publication type:
    Article
    9

    <sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263470
    By:
    • Verhoeff, Sarah R.;
    • van de Donk, Pim P.;
    • Aarntzen, Erik H. J. G.;
    • Oosting, Sjoukje F.;
    • Brouwers, Adrienne H.;
    • Miedema, Iris H. C.;
    • Voortman, Jens;
    • van Oordt, Willemien C. Menke-van der Houven;
    • Boellaard, Ronald;
    • Vriens, Dennis;
    • Slingerland, Marije;
    • Hermsen, Rick;
    • Grunsven, Ilse van Engen-van;
    • Heskamp, Sandra;
    • van Herpen, Carla M. L.
    Publication type:
    Article
    10
    11
    12

    <sup>89</sup>Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224568
    By:
    • Jauw, Yvonne W. S.;
    • O’Donoghue, Joseph A.;
    • Zijlstra, Josée M.;
    • Hoekstra, Otto S.;
    • Willemien Menke-van der Houven van Oordt, C.;
    • Morschhauser, Franck;
    • Carrasquillo, Jorge A.;
    • Zweegman, Sonja;
    • Taskar, Neeta Pandit-;
    • Lammertsma, Adriaan A.;
    • van Dongen, Guus. A. M. S.;
    • Boellaard, Ronald;
    • Weber, Wolfgang A.;
    • Huisman, Marc C.
    Publication type:
    Article
    13

    ImmunoPET imaging to assess target engagement: Experience from 89Zr‐anti‐HER3 mAb (GSK2849330) in patients with solid tumors.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.214726
    By:
    • Willemien Menke‐van der Houven van Oordt, C.;
    • McGeoch, Adam;
    • Bergstrom, Mats;
    • McSherry, Iain;
    • Smith, Deborah A.;
    • Cleveland, Matthew;
    • Al‐Azzam, Wasfi;
    • Liangfu Chen;
    • Verheul, Henk;
    • Hoekstra, Otto S.;
    • Vugts, Danielle J.;
    • Freedman, Immanuel;
    • Huisman, Marc;
    • Matheny, Chris;
    • Guus van Dongen;
    • Sean Zhang
    Publication type:
    Article
    14

    Immuno-PET Imaging to Assess Target Engagement: Experience from <sup>89</sup>Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 7, p. 902, doi. 10.2967/jnumed.118.214726
    By:
    • Menke-van der Houven van Oordt, C. Willemien;
    • McGeoch, Adam;
    • Bergstrom, Mats;
    • McSherry, Iain;
    • Smith, Deborah A.;
    • Cleveland, Matthew;
    • Al-Azzam, Wasfi;
    • Liangfu Chen;
    • Verheul, Henk;
    • Hoekstra, Otto S.;
    • Vugts, Danielle J.;
    • Freedman, Immanuel;
    • Huisman, Marc;
    • Matheny, Chris;
    • van Dongen, Guus;
    • Sean Zhang
    Publication type:
    Article
    15

    Cost-Utility of the eHealth Application 'Oncokompas', Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial.

    Published in:
    Current Oncology, 2022, v. 29, n. 9, p. 6186, doi. 10.3390/curroncol29090486
    By:
    • Schuit, Anouk S.;
    • Holtmaat, Karen;
    • Coupé, Veerle M. H.;
    • Eerenstein, Simone E. J.;
    • Zijlstra, Josée M.;
    • Eeltink, Corien;
    • Becker-Commissaris, Annemarie;
    • van Zuylen, Lia;
    • van Linde, Myra E.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Sommeijer, Dirkje W.;
    • Verbeek, Nol;
    • Bosscha, Koop;
    • Nandoe Tewarie, Rishi;
    • Sedee, Robert-Jan;
    • de Bree, Remco;
    • de Graeff, Alexander;
    • de Vos, Filip;
    • Cuijpers, Pim;
    • Verdonck-de Leeuw, Irma M.
    Publication type:
    Article
    16
    17

    Pharmacokinetic analysis and simplified uptake measures for tumour lesion [<sup>18</sup>F]F-AraG PET imaging in patients with non-small cell lung cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 2, p. 719, doi. 10.1007/s00259-024-06931-3
    By:
    • Wijngaarden, Jessica E.;
    • Slebe, Maarten;
    • Pouw, Johanna E. E.;
    • Oprea-Lager, Daniela E.;
    • Schuit, Robert C.;
    • Dickhoff, Chris;
    • Levi, Jelena;
    • Windhorst, Albert D.;
    • Oordt, C. Willemien Menke-van der Houven van;
    • Thiele, Andrea;
    • Bahce, Idris;
    • Boellaard, Ronald;
    • Yaqub, Maqsood
    Publication type:
    Article
    18

    <sup>89</sup>Zr-immuno-PET using the anti-LAG-3 tracer [<sup>89</sup>Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 2068, doi. 10.1007/s00259-023-06164-w
    By:
    • Miedema, Iris H.C.;
    • Huisman, Marc C.;
    • Zwezerijnen, Gerben J.C.;
    • Grempler, Rolf;
    • Pitarch, Alejandro Perez;
    • Thiele, Andrea;
    • Hesse, Raphael;
    • Elgadi, Mabrouk;
    • Peltzer, Alexander;
    • Vugts, Danielle J.;
    • van Dongen, Guus A.M.S.;
    • de Gruijl, Tanja D.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Bahce, Idris
    Publication type:
    Article
    19

    Validation of simplified uptake measures against dynamic Patlak K<sub>i</sub> for quantification of lesional <sup>89</sup>Zr-Immuno-PET antibody uptake.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 1897, doi. 10.1007/s00259-023-06151-1
    By:
    • Wijngaarden, Jessica E.;
    • Huisman, Marc C.;
    • Jauw, Yvonne W. S.;
    • van Dongen, Guus A. M. S.;
    • Greuter, Henri N. J. M.;
    • Schuit, Robert C.;
    • Cleveland, Matthew;
    • Gootjes, Elske C.;
    • Vugts, Daniëlle J.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Boellaard, Ronald
    Publication type:
    Article
    20

    Interobserver reproducibility of tumor uptake quantification with <sup>89</sup>Zr-immuno-PET: a multicenter analysis.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1840, doi. 10.1007/s00259-019-04377-6
    By:
    • Jauw, Yvonne W. S.;
    • Bensch, Frederike;
    • Brouwers, Adrienne H.;
    • Hoekstra, Otto S.;
    • Zijlstra, Josée M.;
    • Pieplenbosch, Simone;
    • Schröder, Carolien P.;
    • Zweegman, Sonja;
    • van Dongen, Guus A. M. S.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • de Vries, Elisabeth G. E.;
    • de Vet, Henrica C. W.;
    • Boellaard, Ronald;
    • Huisman, Marc C.
    Publication type:
    Article
    21
    22

    Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-023-00610-6
    By:
    • Mileva, Magdalena;
    • de Vries, Elisabeth G. E.;
    • Guiot, Thomas;
    • Wimana, Zéna;
    • Deleu, Anne-Leen;
    • Schröder, Carolien P.;
    • Lefebvre, Yolene;
    • Paesmans, Marianne;
    • Stroobants, Sigrid;
    • Huizing, Manon;
    • Aftimos, Philippe;
    • Tol, Jolien;
    • Van der Graaf, Winette T. A.;
    • Oyen, Wim J. G.;
    • Vugts, Danielle J.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Brouwers, Adrienne H.;
    • Piccart-Gebhart, Martine;
    • Flamen, Patrick;
    • Gebhart, Géraldine
    Publication type:
    Article
    23

    Non-specific irreversible <sup>89</sup>Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using <sup>89</sup>Zr-immuno-PET.

    Published in:
    EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01079-5
    By:
    • Wijngaarden, Jessica E.;
    • Jauw, Yvonne W. S.;
    • Zwezerijnen, Gerben J. C.;
    • de Wit-van der Veen, Berlinda J.;
    • Vugts, Daniëlle J.;
    • Zijlstra, Josée M.;
    • van Dongen, Guus A. M. S.;
    • Boellaard, Ronald;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Huisman, Marc C.
    Publication type:
    Article
    24
    25
    26

    Intrapatient 16α-[<sup>18</sup>F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor–Positive Metastatic Breast Cancer.

    Published in:
    Journal of Nuclear Medicine, 2025, v. 66, n. 2, p. 194, doi. 10.2967/jnumed.124.268984
    By:
    • van Geel, Jasper J.L.;
    • Moustaquim, Jasmine;
    • Boers, Jorianne;
    • Elias, Sjoerd G.;
    • Smeets, Esther M.M.;
    • Knip, Jelijn J.;
    • Glaudemans, Andor W.J.M.;
    • de Vries, Erik F.J.;
    • Hospers, Geke A.P.;
    • van Kruchten, Michel;
    • Stokkel, Marcel;
    • Oprea-Lager, Daniela E.;
    • Menke-van der Houven van Oordt, Willemien C.;
    • de Vries, Elisabeth G.E.;
    • Schröder, Carolina P.
    Publication type:
    Article
    27

    Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1540, doi. 10.2967/jnumed.124.267636
    By:
    • Eisses, Bertha;
    • van Geel, Jasper J.L.;
    • Brouwers, Adrienne H.;
    • Bensch, Frederike;
    • Elias, Sjoerd G.;
    • Kuip, Evelien J.M.;
    • Jager, Agnes;
    • van der Vegt, Bert;
    • Lub-de Hooge, Marjolijn N.;
    • Emmering, Jasper;
    • Arens, Anne I.J.;
    • Zwezerijnen, Gerben J.C.;
    • Vugts, Daniëlle J.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • de Vries, Elisabeth G.E.;
    • Schröder, Carolina P.;
    • Bensch, F.;
    • van Es, S.;
    • van Essen-Eisses, B.;
    • Boers, J.
    Publication type:
    Article
    28
    29
    30

    PET‐CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients.

    Published in:
    Advanced Materials, 2022, v. 34, n. 21, p. 1, doi. 10.1002/adma.202201043
    By:
    • Miedema, Iris H. C.;
    • Zwezerijnen, Gerben J. C.;
    • Huisman, Marc C.;
    • Doeleman, Ellen;
    • Mathijssen, Ron H. J.;
    • Lammers, Twan;
    • Hu, Qizhi;
    • van Dongen, Guus A. M. S.;
    • Rijcken, Cristianne J. F.;
    • Vugts, Danielle J.;
    • Menke‐van der Houven van Oordt, C. Willemien
    Publication type:
    Article
    31

    Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.

    Published in:
    Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01073-7
    By:
    • Eijkelboom, Anouk H.;
    • de Munck, Linda;
    • Vrancken Peeters, Marie-Jeanne T. F. D.;
    • Broeders, Mireille J. M.;
    • Strobbe, Luc J. A.;
    • Bos, Monique E. M. M.;
    • Schmidt, Marjanka K.;
    • Guerrero Paez, Cristina;
    • Smidt, Marjolein L.;
    • Bessems, Maud;
    • Verloop, Janneke;
    • Linn, Sabine;
    • Lobbes, Marc B. I.;
    • Honkoop, Aafke H.;
    • van den Bongard, Desirée H. J. G.;
    • Westenend, Pieter J.;
    • Wesseling, Jelle;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Tjan-Heijnen, Vivianne C. G.;
    • Siesling, Sabine
    Publication type:
    Article
    32
    33

    Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study.

    Published in:
    EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00627-z
    By:
    • Mammatas, Lemonitsa H.;
    • Venema, Clasina M.;
    • Schröder, Carolina P.;
    • de Vet, Henrica C. W.;
    • van Kruchten, Michel;
    • Glaudemans, Andor W. J. M.;
    • Yaqub, Maqsood M.;
    • Verheul, Henk M. W.;
    • Boven, Epie;
    • van der Vegt, Bert;
    • de Vries, Erik F. J.;
    • de Vries, Elisabeth G. E.;
    • Hoekstra, Otto S.;
    • Hospers, Geke A. P.;
    • der Houven van Oordt, C. Willemien Menke-van
    Publication type:
    Article
    34
    35
    36
    37

    Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol.

    Published in:
    Cancers, 2021, v. 13, n. 15, p. 3902, doi. 10.3390/cancers13153902
    By:
    • Geboers, Bart;
    • Timmer, Florentine E. F.;
    • Ruarus, Alette H.;
    • Pouw, Johanna E. E.;
    • Schouten, Evelien A. C.;
    • Bakker, Joyce;
    • Puijk, Robbert S.;
    • Nieuwenhuizen, Sanne;
    • Dijkstra, Madelon;
    • van den Tol, M. Petrousjka;
    • de Vries, Jan J. J.;
    • Oprea-Lager, Daniela E.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • van der Vliet, Hans J.;
    • Wilmink, Johanna W.;
    • Scheffer, Hester J.;
    • de Gruijl, Tanja D.;
    • Meijerink, Martijn R.
    Publication type:
    Article
    38
    39

    Correlation between Histopathological Prognostic Tumor Characteristics and [ 18 F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.

    Published in:
    Diagnostics (2075-4418), 2024, v. 14, n. 4, p. 416, doi. 10.3390/diagnostics14040416
    By:
    • Boers, Jorianne;
    • Eisses, Bertha;
    • Zwager, Mieke C.;
    • van Geel, Jasper J. L.;
    • Bensch, Frederike;
    • de Vries, Erik F. J.;
    • Hospers, Geke A. P.;
    • Glaudemans, Andor W. J. M.;
    • Brouwers, Adrienne H.;
    • den Dekker, Martijn A. M.;
    • Elias, Sjoerd G.;
    • Kuip, Evelien J. M.;
    • van Herpen, Carla M. L.;
    • Jager, Agnes;
    • van der Veldt, Astrid A. M.;
    • Oprea-Lager, Daniela E.;
    • de Vries, Elisabeth G. E.;
    • van der Vegt, Bert;
    • Menke-van der Houven van Oordt, Willemien C.;
    • Schröder, Carolina P.
    Publication type:
    Article
    40

    3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18 F-Fluorodeoxyglucose and 89 Zr-Rituximab PET Scans.

    Published in:
    Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 596, doi. 10.3390/diagnostics12030596
    By:
    • de Vries, Bart M.;
    • Golla, Sandeep S. V.;
    • Zwezerijnen, Gerben J. C.;
    • Hoekstra, Otto S.;
    • Jauw, Yvonne W. S.;
    • Huisman, Marc C.;
    • van Dongen, Guus A. M. S.;
    • Menke-van der Houven van Oordt, Willemien C.;
    • Zijlstra-Baalbergen, Josée J. M.;
    • Mesotten, Liesbet;
    • Boellaard, Ronald;
    • Yaqub, Maqsood
    Publication type:
    Article
    41

    Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.

    Published in:
    EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0358-8
    By:
    • Jauw, Yvonne W. S.;
    • Huisman, Marc C.;
    • Nayak, Tapan K.;
    • Vugts, Danielle J.;
    • Christen, Randolph;
    • Naegelen, Valerie Meresse;
    • Ruettinger, Dominik;
    • Heil, Florian;
    • Lammertsma, Adriaan A.;
    • Verheul, Henk M. W.;
    • Hoekstra, Otto S.;
    • van Dongen, Guus A. M. S.;
    • Menke-van der Houven van Oordt, C. Willemien
    Publication type:
    Article
    42

    Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study.

    Published in:
    Breast Cancer Research & Treatment, 2023, v. 197, n. 1, p. 161, doi. 10.1007/s10549-022-06732-y
    By:
    • Eijkelboom, Anouk H.;
    • de Munck, Linda;
    • Menke-van der Houven van Oordt, C. Willemien;
    • Broeders, Mireille J. M.;
    • van den Bongard, Desiree H. J. G.;
    • Strobbe, Luc J. A.;
    • Mureau, Marc A. M.;
    • Lobbes, Marc B. I.;
    • Westenend, Pieter J.;
    • Koppert, Linetta B.;
    • Jager, Agnes;
    • Siemerink, Ester J. M.;
    • Wesseling, Jelle;
    • Verkooijen, Helena M.;
    • Vrancken Peeters, Marie-Jeanne T. F. D.;
    • Smidt, Marjolein L.;
    • Tjan-Heijnen, Vivianne C. G.;
    • Siesling, Sabine;
    • The COVID and Cancer Care-NL Consortium;
    • van Hoeve, J. C.
    Publication type:
    Article
    43
    44
    45
    46

    Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers.

    Published in:
    2019
    By:
    • Dreijerink, Koen M A;
    • Rijken, Johannes A;
    • Compaijen, C J;
    • Timmers, Henri J L M;
    • van der Horst-Schrivers, Anouk N A;
    • van Leeuwaarde, Rachel S;
    • van Dam, P Sytze;
    • Leemans, C René;
    • van Dam, Eveline W C M;
    • Dickhoff, Chris;
    • Dommering, Charlotte J;
    • de Graaf, Pim;
    • Zwezerijnen, G J C;
    • van der Valk, Paul;
    • Menke-Van der Houven van Oordt, C Willemien;
    • Hensen, Erik F;
    • Corssmit, Eleonora P M;
    • Eekhoff, E Marelise W
    Publication type:
    journal article